HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Roland Schmidt Selected Research
Roland Schmidt Research Topics
Disease
4
Pain (Aches)
10/2016 - 02/2007
3
Wounds and Injuries (Trauma)
10/2022 - 01/2012
3
Inflammation (Inflammations)
06/2013 - 04/2005
3
Atherosclerosis
06/2013 - 02/2006
3
Myocardial Infarction
02/2008 - 11/2002
3
Rupture
02/2008 - 04/2005
2
Neuralgia (Stump Neuralgia)
01/2018 - 12/2012
2
Coronary Artery Disease (Coronary Atherosclerosis)
09/2014 - 09/2013
2
Atherosclerotic Plaque (Atheroma)
03/2010 - 04/2005
2
Neoplasms (Cancer)
09/2007 - 02/2006
2
Infections
01/2006 - 05/2003
1
Ecchymosis
10/2022
1
Anastomotic Leak
11/2019
1
Disease Progression
08/2017
1
Intestinal Volvulus (Volvulus)
08/2017
1
Fibrosis (Cirrhosis)
03/2016
1
Atrophy
03/2016
1
Hereditary Sensory and Autonomic Neuropathies (HSAN)
01/2016
1
Erythromelalgia (Erythermalgia)
01/2016
1
Congenital Pain Insensitivity
01/2016
1
Chronic Pain
01/2016
1
Thrombosis (Thrombus)
06/2013
1
Altitude Sickness (Mountain Sickness)
12/2012
1
Pulmonary Edema
12/2012
1
Cardiomyopathies (Cardiomyopathy)
07/2011
1
Aortic Valve Stenosis (Aortic Stenosis)
07/2011
1
Intrinsic Positive-Pressure Respiration
05/2009
1
Hypoxia (Hypoxemia)
05/2009
1
Pruritus (Itching)
07/2008
1
Stable Angina
02/2006
1
Neointima
04/2004
1
Anosmia
06/2002
Drug/Important Bio-Agent (IBA)
6
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
03/2016 - 01/2006
5
Matrix Metalloproteinases (MMPs)
IBA
03/2016 - 01/2006
3
Metalloproteases (Metalloproteinases)
IBA
07/2011 - 02/2006
3
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2006 - 11/2002
2
Analgesics (Analgesic Drugs)
IBA
11/2019 - 01/2018
2
C-Reactive Protein
IBA
09/2014 - 09/2013
2
Peptide Hydrolases (Proteases)
FDA Link
02/2008 - 04/2005
1
Complement System Proteins (Complement)
IBA
10/2022
1
Sodium Channels (Sodium Channel)
IBA
10/2016
1
Nerve Growth Factor (NGF)
IBA
01/2016
1
Tetrodotoxin (Tetradotoxin)
IBA
01/2016
1
Voltage-Gated Sodium Channels
IBA
01/2016
1
Fibrinogen (Factor I)
FDA Link
09/2014
1
Nitric Oxide Synthase (NO Synthase)
IBA
12/2012
1
Lidocaine (Xylocaine)
FDA Link
Generic
12/2012
1
Local Anesthetics
IBA
12/2012
1
Sodium Channel Blockers
IBA
12/2012
1
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
12/2012
1
Matrix Metalloproteinase 14 (MT1-MMP)
IBA
07/2011
1
Proteins (Proteins, Gene)
FDA Link
07/2011
1
Apolipoproteins E (ApoE)
IBA
03/2010
1
Codeine (Codeine Phosphate)
FDA Link
Generic
07/2008
1
NF-kappa B (NF-kB)
IBA
02/2008
1
Keratin-20 (Cytokeratin 20)
IBA
09/2007
1
Catecholamines
IBA
02/2007
1
Messenger RNA (mRNA)
IBA
01/2006
1
Urokinase Plasminogen Activator Receptors
IBA
01/2006
1
oxidized low density lipoprotein
IBA
04/2005
1
Sirolimus (Rapamycin)
FDA Link
04/2004
1
Integrin alpha4beta1 (VLA-4)
IBA
05/2003
1
Lymphocyte Function-Associated Antigen-1 (LFA-1)
IBA
05/2003
1
Drinking Water
IBA
06/2002
1
Glutaral (Glutaraldehyde)
IBA
06/2002
1
isobutyraldehyde
IBA
06/2002
Therapy/Procedure
2
Therapeutics
08/2017 - 05/2009
2
Operative Surgical Procedures
08/2017 - 01/2012
1
Seat Belts (Seat Belt)
10/2022
1
Laparotomy
07/2020
1
Operative Time
11/2019
1
Colectomy
08/2017
1
Percutaneous Coronary Intervention
09/2013
1
Heart Transplantation (Grafting, Heart)
07/2011
1
Positive-Pressure Respiration (Positive End-Expiratory Pressure)
05/2009
1
Stents
04/2004